Yaobin Lin

Fujian Medical University — China

Medicine · Health Sciences

16h-index741citations79works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(21), Lung Cancer Treatments and Mutations(20), Cancer Immunotherapy and Biomarkers(11), Lung Cancer Research Studies(9), Cancer-related molecular mechanisms research(8)

Publications79 total

A signature of plasma exosomal miRNAs predict therapeutic efficacy to neoadjuvant immunotherapy in patients with non-small cell lung cancer
Journal of Translational Internal Medicine·2025· 1 citedOpen Access
ZC3H18 regulates alternative splicing and related genes in cervical cancer
Frontiers in Genetics·2025Open Access
Adjuvant icotinib for resected EGFR-mutated stage II–IIIA non-small-cell lung cancer (ICTAN, GASTO1002): a randomized comparison study
Signal Transduction and Targeted Therapy·2025· 2 citedOpen Access
Clinical characteristics and outcomes among patients with subcutaneous panniculitis-like T-cell lymphoma
Expert Review of Anticancer Therapy·2025
Mendelian randomization analysis reveals the causal relationship between immune cells and leukemia
Discover Oncology·2025Open Access
Four-year outcomes with perioperative toripalimab plus chemotherapy in resectable stage III non-small cell lung cancer (NeoTAP01 study)
Journal of Thoracic Disease·2025Open Access
Sex-specific differences in reproductive tract lymphomas: epidemiology, clinical features, and treatment outcomes
The Oncologist·2025Open Access
Safety and necessity of omitting mediastinal lymph node dissection in cN0/N1 non-small cell lung cancer after neoadjuvant immunotherapy
Frontiers in Immunology·2025· 3 citedOpen Access
TFDP1 drives triple-negative breast Cancer development through senescence suppression and serves as a therapeutic target for topotecan
International Journal of Biological Macromolecules·2025· 2 cited
Safety and Efficacy of Unresectable Malignant Cardiac Tumors Treated with Concurrent Chemoradiation Therapy Using a 1.5T MR-Linac (GASTO-1078)
International Journal of Radiation Oncology*Biology*Physics·2025· 4 cited
Causal relationships between body composition and hematological malignancies: a multivariable mendelian randomization analysis
Cancer Causes & Control·2025· 1 cited
Incidence trends and prognostic factors in head and neck MALT lymphoma
Annals of Hematology·2025· 1 citedOpen Access
[Advances of Neoadjuvant Targeted Therapy in ALK-positive Non-small Cell Lung Cancer].
PubMed·2024Open Access
Economic evaluation of treating invasive aspergillosis with isavuconazole, posaconazole and voriconazole in China
Future Microbiology·2024· 2 citedOpen Access
Adjuvant icotinib of 12 months or 6 months versus observation following adjuvant chemotherapy for resected EGFR-mutated stage II–IIIA non-small cell lung cancer (ICTAN, GASTO1002): a randomized phase 3 trial
2024Open Access
Dynamics of peripheral blood inflammatory index predict tumor pathological response and survival among patients with locally advanced non-small cell lung cancer who underwent neoadjuvant immunochemotherapy: a multi-cohort retrospective study
Frontiers in Immunology·2024· 5 citedOpen Access
Correction: A novel lncRNA SNHG29 regulates EP300- related histone acetylation modification and inhibits FLT3-ITD AML development
Leukemia·2024Open Access
Impact of treatment on the prognosis of childhood in hepatoblastoma: A SEER based analysis
Heliyon·2024· 2 citedOpen Access
Investigation of the role of personalized molecular residual disease in the assessment of high-risk non-small cell lung cancer (NSCLC) post-operation.
Journal of Clinical Oncology·2024· 1 cited
Efficacy and Safety of neoadjuvant tislelizumab plus chemotherapy for the Treatment of non-small cell lung cancer: A Single-Arm Meta-Analysis Among Chinese Patients
2024Open Access
page 1 of 4Next →

Frequent Co-authors

Hao Long(18), Ze-Rui Zhao(13), Wenyu Zhai(11), Bing-Yu Rao(9), Yongbin Lin(8), Ze-Rui Zhao(7), Yizhi Wang(7), Fangfang Duan(7), Junye Wang(6), Shan Liu(5), Junxin Wu(5), Lie Zheng(5), Jianhua Fu(4), Long Jiang(4), Shanshan Jiang(4), Zehua Xie(4), Yuheng Zhou(4), Zhichao Lin(4), Hui Yu(3), Sihan Huang(3)